These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2875183)

  • 21. Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines.
    Ross ST; Franz RG; Wilson JW; Brenner M; DeMarinis RM; Hieble JP; Sarau HM
    J Med Chem; 1986 May; 29(5):733-40. PubMed ID: 2871192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA; Zahniser NR
    Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
    Seiler MP; Stoll AP; Closse A; Frick W; Jaton A; Vigouret JM
    J Med Chem; 1986 Jun; 29(6):912-7. PubMed ID: 3712381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture.
    Bryson SE; Drew GM; Hall AS; Ball SG; Balmforth AJ
    Eur J Pharmacol; 1992 Jan; 225(1):1-5. PubMed ID: 1347268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonist.
    Horn AS; Tepper P; Van der Weide J; Watanabe M; Grigoriadis D; Seeman P
    Pharm Weekbl Sci; 1985 Oct; 7(5):208-11. PubMed ID: 2933633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
    Rollema H; Feenstra MG; Grol CJ; Lewis MH; Staples L; Mailman RB
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):338-45. PubMed ID: 3736679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Z1046: biochemical characterization of its dopaminergic activity.
    Fantoni M; Moriggi E; Bisiani C; Masotto C; Pocchiari F; Semeraro C
    Acta Physiol Hung; 1996; 84(3):279-80. PubMed ID: 9219606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
    J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Horn AS
    Eur J Pharmacol; 1985 Feb; 109(2):229-40. PubMed ID: 3922776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of some [N-(2-haloalkyl)amino]tetralin derivatives as potential irreversible labels for bovine anterior pituitary D2 dopamine receptors.
    Hall AW; Taylor RJ; Simmonds SH; Strange PG
    J Med Chem; 1987 Oct; 30(10):1879-87. PubMed ID: 3656361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.
    Sibley DR; Leff SE; Creese I
    Life Sci; 1982 Aug; 31(7):637-45. PubMed ID: 6127585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Timmermans PB; Wynberg H; Horn AS
    Eur J Pharmacol; 1986 May; 124(1-2):93-106. PubMed ID: 3720849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
    Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
    Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C; De Vries JB; Dijkstra D; Horn AS
    Eur J Pharmacol; 1981 Apr; 70(4):541-50. PubMed ID: 6113149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and dopamine receptor affinities of 2-(4-fluoro-3- hydroxyphenyl)ethylamine and N-substituted derivatives.
    Claudi F; Cardellini M; Cingolani GM; Piergentili A; Peruzzi G; Balduini W
    J Med Chem; 1990 Sep; 33(9):2408-12. PubMed ID: 1975274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins.
    DeMarinis RM; Shah DH; Hall RF; Hieble JP; Pendleton RG
    J Med Chem; 1982 Feb; 25(2):136-41. PubMed ID: 6120238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.